Nikola
- BIOTECHNOLOGY
- C&E Exclusion Filter
- C&E Industry News Filter
- cards
- Companies
- Content Types
- Corporate
- Corporate/Industrial News
- correct success
- credit
- credit score
- debit cards
- Defiance Next Gen SPAC Derived ETF
- disruptions
- docu
- docusign
- dump
- EARNINGS
- Economic News
- Factiva Filters
- federal reserve
- Finance
- Financial Performance
- Healthcare
- Healthcare/Life Sciences
- Hood
- Increases
- industrial news
- interest rates
- investors
- life sciences
- Looming
- Monetary Policy
- money
- MoneyLosing
- Nikola
- NKLA
- rate
- Rivian Automotive
- RIVN
- Robinhood Markets
- share price movement
- Share Price Movement/Disruptions
- Shares
- SPAK
- SYND
- WSJ-PRO-WSJ.com
0


Moonshot stocks are coming back to Earth. As the Federal Reserve moves closer to raising interest rates, investors are repricing their bets on one of the riskiest corners of the market: shares of companies that don’t make money. Cash-burning technology firms, biotechnology companies without any approved drugs and startups that listed quickly via mergers with […]
Pages
- 1